Drug-labels.com Search Menu

Oilatum Product Monograph

Updated:
Facts
Status:
Over-the-counter (OTC) Current status: Cancelled Post Market
Strength:
63.4 %
Active ingredient:

Product Monograph - Oilatum

INDICATIONS AND CLINICAL USE

OILATUM® (Light Liquid Paraffin (LLP), 63.40% w/w) relieves dry, itchy, sensitive skin, softens and hydrates the skin and helps protect against further drying.

CONTRAINDICATIONS

No contraindications identified.

WARNINGS AND PRECAUTIONS

OILATUM® should be used with caution in patients with a known sensitivity to LLP or to any of the excipients in the preparation.

OILATUM® is for external use only. Patients should be advised to avoid contact with the eyes. If contact occurs, rinse with water. If skin irritation occurs, patients should discontinue use. Patients should be advised to consult a healthcare practitioner of symptoms worsen or last for more than 7 days.

Sexual Function/Reproduction

There are no data on the use of cutaneous LLP on human fertility.

Special Populations

Pregnant Women: No effects during pregnancy are anticipated, since systemic exposure to LLP is expected to be low

Nursing Women: It is not known if LLP is excreted in human milk. Risk to the infant is likely to be low since systemic exposure is low.

Patients should be advised to ensure that any residual product is fully washed off the breast prior to breast-feeding.

ADVERSE REACTIONS

Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as: very common (≥1/10), common (≥1/100 and

<1/10), uncommon (≥1/1,000 and <1/100), rare (≥1/10,000 and <1/1,000); very rare

(<1/10,000) and not known (cannot be estimated from the available data).

Post-Market Adverse Drug Reactions

Immune system disorders

Rare: Application site hypersensitivity reactions including application site dermatitis

Skin and subcutaneous tissue disorders

Rare: Application site reactions including application site irritation, rash erythema, prurititus.

DRUG INTERACTIONS

No drug interaction studies have been conducted with cutaneous OILATUM®.

Considering the low level of systemic absorption, drug interactions are unlikely to occur.

DOSAGE AND ADMINISTRATION

For cutaneous use only.

OILATUM® should always be used with water, either added to bath water, applied to wet skin or used as a shower gel.

OILATUM® is an effective cleanser and should be used instead of soap to cleanse the skin.

OILATUM® may be used as frequently as necessary.

Adults, adolescents and children

Shower oil

Shower as usual. Apply OILATUM® to wet skin and massage gently. Rinse briefly and gently pat the skin dry with a clean towel.

Bath additive

In an eight inch (20 cm) bath of water add 10-20 mL and mix well.

Soak for 10 minutes. Gently pat the skin dry with a clean towel.

Guard against slipping in tub or shower.

In cases of extensive areas of dry skin ensure complete coverage by immersion.

For skin cleansing, apply a small amount of OILATUM® additive onto wet skin. Rinse and gently pat the skin dry with a clean towel.

Infants

Bath additive

Add 5-10 mL to a basin of water (approximately 15 litres). Apply over entire body with a sponge. Gently pat the skin dry with a clean towel.

SYMPTOMS AND TREATMENT OF OVERDOSAGE

OILATUM® is intended for cutaneous use only. Accidental ingestion may cause gastrointestinal irritation with nausea, vomiting and diarrhoea.

In case of accidental ingestion management should be as clinically indicated or as recommended by the regional Poison Control Centre.

For management of a suspected overdose, contact your regional Poison Control Centre.

DESCRIPTION AND COMPOSITION

OILATUM® contains light liquid paraffin 63.40% w/w. OILATUM® also contains fragrance floral-spice, isopropyl palmitate, lanolin alcohol acetylated, PEG 40 sorbitan peroleate, and polyethylene glycol 400 dilaurate.

AVAILABILITY

OILATUM® (Light Liquid Paraffin (LLP), 63.40% w/w) is available in a 250 mL bottle.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02034670

Revision date stated in the text: May 7, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Oilatum

Rx or OTC
Over-the-counter (OTC)?
DIN 02034670
Schedule(s) NON-PRESCRIPTION DRUGS
Active ingredient(s) Mineral oil light 63.4 %
Dosage form(s) Liquid
Route(s) of administration Topical
Company GLAXOSMITHKLINE INC
Current status Cancelled Post Market
Current status date February 28, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.